The association between race and survival in glioblastoma patients in the US: A retrospective cohort study-Reference-Cited by-同舟云学术

The association between race and survival in glioblastoma patients in the US: A retrospective cohort study

Published:2018-06-21 Issue:6 Volume:13 Page:e0198581
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bohn Andrew,Braley Alexander,Rodriguez de la Vega Pura,Zevallos Juan Carlos,Barengo Noël C.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference23 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008–2012;QT Ostrom;Neuro Oncol,2015

2. Epidemiologic and molecular prognostic review of glioblastoma;JP Thakkar;Cancer Epidemiol Biomarkers Prev,2014

3. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825;H Gittleman;Neuro Oncol,2017

4. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma;R Rhome;J Neurooncol,2016

5. Racial differences in survival after diagnosis with primary malignant brain tumor;JS Barnholtz-Sloan;Cancer,2003

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robust AI-Driven Segmentation of Glioblastoma T1c and FLAIR MRI Series and the Low Variability of the MRIMath© Smart Manual Contouring Platform;Diagnostics;2024-05-21

2. Migrasomal autophagosomes relieve endoplasmic reticulum stress in glioblastoma cells;BMC Biology;2024-01-30

3. Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial;Nature Communications;2024-01-12

4. Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward;Neuro-Oncology Advances;2024-01-01

5. The role of lobectomy in glioblastoma management: A systematic review and meta-analysis;Brain and Spine;2024